Goodwill Pharma Plc., founded in 1997, is a leading pharmaceutical player headquartered in Hungary and listed on the Hungarian Stock Exchange. With the slogan, "Good health - Good life - Good will", the company underscores its dedication to healthcare innovation and future growth.
Ranked among the top ten pharmaceutical companies in Hungary, Goodwill Pharma has a robust presence across 12 Central and Eastern European countries, including Serbia, Poland, and Slovakia. Its comprehensive business model integrates production, wholesale, distribution, and marketing, supported by a skilled sales force exceeding 100 representatives.
The company's versatile portfolio comprises both innovative and branded generic pharmaceuticals, focusing on diverse health fields such as rheumatology, neurology, and gastroenterology. Flagship products like Albert Szent-Györgyi and Fortacell bolster its strong foothold in the dietary and medical supplements market.
Commitment to EU GMP and FDA standards exemplifies their dedication to quality. The company's market expansion and strategic locality position Goodwill Pharma as a promising investment opportunity in the CEE pharmaceutical landscape.